Noah L. Rosenberg
CIK 1579649 · CMO · last filed 2026-06-09
Noah L. Rosenberg is a CMO who has filed 21 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for VRCA, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$356.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.56M
4
21
-$356.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRCA | CMO | 2,357 | $5.73 | $13.5K | $10.0K | 3 | 2026-06-09 |
| TVTX | Chief Medical Officer | 49,021 | $52.04 | $2.55M | -$234.8K | 8 | 2021-08-17 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Chief Medical Officer | 27,555 | — | — | -$131.9K | 9 | 2020-09-23 |
| ESPR | Chief Medical Officer | — | $3.15 | — | $0 | 1 | 2013-07-25 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2025-11-25 | VRCA | Buy (P) | +2,357 | $10.0K | EDGAR |
| 2025-03-26 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2021-08-17 | TVTX | Mixed | +3,093 | -$24.1K | EDGAR |
| 2021-07-29 | TVTX | Sell (S) | −1,250 | -$17.3K | EDGAR |
| 2021-05-13 | TVTX | Sell (S) | −750 | -$14.5K | EDGAR |
| 2021-02-09 | TVTX | Sell (S) | −2,250 | -$70.9K | EDGAR |
| 2021-02-05 | TVTX | Grant (A) | +4,500 | $0 | EDGAR |
| 2021-02-03 | TVTX | Sell (S) | −1,813 | -$52.4K | EDGAR |
| 2021-02-02 | TVTX | Mixed | +3,187 | -$55.7K | EDGAR |